Authors:
AJANI JA
FAIRWEATHER J
DUMAS P
PATT YZ
PAZDUR R
MANSFIELD PF
Citation: Ja. Ajani et al., PHASE-II STUDY OF TAXOL IN PATIENTS WITH ADVANCED GASTRIC-CARCINOMA, The cancer journal from Scientific American, 4(4), 1998, pp. 269-274
Citation: H. Takiuchi et Ja. Ajani, URACIL-TEGAFUR IN GASTRIC-CARCINOMA - A COMPREHENSIVE REVIEW, Journal of clinical oncology, 16(8), 1998, pp. 2877-2885
Authors:
DIAMANDIDOU E
AJANI JA
YANG DJ
CHUANG VP
BROWN CA
CARRASCO HC
LAWRENCE DD
WALLACE S
Citation: E. Diamandidou et al., 2-PHASE STUDY OF HEPATIC-ARTERY VASCULAR OCCLUSION WITH MICROENCAPSULATED CISPLATIN IN PATIENTS WITH LIVER METASTASES FROM NEUROENDOCRINE TUMORS, American journal of roentgenology, 170(2), 1998, pp. 339-344
Citation: E. Rivera et Ja. Ajani, DOXORUBICIN, STREPTOZOCIN, AND 5-FLUOROURACIL CHEMOTHERAPY FOR PATIENTS WITH METASTATIC ISLET-CELL CARCINOMA, American journal of clinical oncology, 21(1), 1998, pp. 36-38
Citation: Ja. Ajani et al., PHASE-II STUDY OF PROLONGED INFUSION OF TAXOL IN PATIENTS WITH METASTATIC COLORECTAL-CARCINOMA, Investigational new drugs, 16(2), 1998, pp. 175-177
Citation: Ja. Ajani, CURRENT STATUS OF NEW DRUGS AND MULTIDISCIPLINARY APPROACHES IN PATIENTS WITH CARCINOMA OF THE ESOPHAGUS, Chest, 113(1), 1998, pp. 112-119
Citation: Ja. Ajani et al., PACLITAXEL IN THE TREATMENT OF PATIENTS WITH UPPER GASTROINTESTINAL CARCINOMAS, Seminars in oncology, 23(5), 1996, pp. 55-58
Authors:
AJANI JA
ROTH JA
PUTNAM JB
WALSH G
LYNCH PM
ROUBEIN LD
RYAN MB
NATRAJAN G
GOULD P
Citation: Ja. Ajani et al., FEASIBILITY OF 5 COURSES OF PREOPERATIVE CHEMOTHERAPY IN PATIENTS WITH RESECTABLE ADENOCARCINOMA OF THE ESOPHAGUS OR GASTROESOPHAGEAL JUNCTION, European journal of cancer, 31A(5), 1995, pp. 665-670
Citation: Ja. Ajani et al., POTENTIALLY RESECTABLE GASTRIC-CARCINOMA - CURRENT APPROACHES TO STAGING AND PREOPERATIVE THERAPY, World journal of surgery, 19(2), 1995, pp. 216-220
Authors:
RICH TA
SKIBBER JM
AJANI JA
BUCHHOLZ DJ
CLEARY KR
DUBROW RA
LEVIN B
LYNCH PM
METERISSIAN SH
ROUBEIN LD
OTA DM
Citation: Ta. Rich et al., PREOPERATIVE INFUSIONAL CHEMORADIATION THERAPY FOR STAGE T3 RECTAL-CANCER, International journal of radiation oncology, biology, physics, 32(4), 1995, pp. 1025-1029
Authors:
WEINSTEIN GD
RICH TA
SHUMATE CR
SKIBBER JM
CLEARY KR
AJANI JA
OTA DM
Citation: Gd. Weinstein et al., PREOPERATIVE INFUSIONAL CHEMORADIATION AND SURGERY WITH OR WITHOUT ANELECTRON-BEAM INTRAOPERATIVE BOOST FOR ADVANCED PRIMARY RECTAL-CANCER, International journal of radiation oncology, biology, physics, 32(1), 1995, pp. 197-204
Authors:
PAZDUR R
BREADY B
AJANI JA
ABBRUZZESE JL
MARKOWITZ A
SUGARMAN S
JONES D
LEVIN B
Citation: R. Pazdur et al., PHASE-II TRIAL OF ISOTRETINOIN AND RECOMBINANT INTERFERON ALFA-2A IN METASTATIC COLORECTAL-CARCINOMA, American journal of clinical oncology, 18(5), 1995, pp. 436-438
Citation: Yh. Kim et al., VALUE OF SERIAL CARCINOEMBRYONIC ANTIGEN LEVELS IN PATIENTS WITH RESECTABLE ADENOCARCINOMA OF THE ESOPHAGUS AND STOMACH, Cancer, 75(2), 1995, pp. 451-456
Authors:
AJANI JA
ILSON DH
DAUGHERTY K
PAZDUR R
LYNCH PM
KELSEN DP
Citation: Ja. Ajani et al., ACTIVITY OF TAXOL IN PATIENTS WITH SQUAMOUS-CELL CARCINOMA AND ADENOCARCINOMA OF THE ESOPHAGUS, Journal of the National Cancer Institute, 86(14), 1994, pp. 1086-1091
Authors:
AJANI JA
DODD LG
DAUGHERTY K
WARKENTIN D
ILSON DH
Citation: Ja. Ajani et al., TAXOL-INDUCED SOFT-TISSUE INJURY SECONDARY TO EXTRAVASATION - CHARACTERIZATION BY HISTOPATHOLOGY AND CLINICAL COURSE, Journal of the National Cancer Institute, 86(1), 1994, pp. 51-53
Authors:
MOORE DF
PAZDUR R
ABBRUZZESE JL
AJANI JA
DUBOVSKY DW
WADE JL
BELT RJ
MANGOLD C
BREADY B
WINN RJ
Citation: Df. Moore et al., PHASE-II TRIAL OF EDATREXATE IN PATIENTS WITH ADVANCED PANCREATIC ADENOCARCINOMA, Annals of oncology, 5(3), 1994, pp. 286-287
Citation: Ta. Rich et Ja. Ajani, HIGH-DOSE EXTERNAL-BEAM RADIATION-THERAPY WITH OR WITHOUT CONCOMITANTCHEMOTHERAPY FOR ESOPHAGEAL-CARCINOMA, Annals of oncology, 5, 1994, pp. 190000009-190000015